During the past decade, Pulmonary Medicine Center of Chattanooga-Hixson conducted 77 clinical trials. In the 10-year time frame, 77 clinical trials started and 43 clinical trials were completed, i.e. on average, 55.8% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 40 clinical trials were completed. i.e. 666.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pulmonary Medicine Center of Chattanooga-Hixson" #1 sponsor was "National Cancer Institute (NCI)" with 48 trials, followed by "SWOG Cancer Research Network" with 24 trials sponsored, "Alliance for Clinical Trials in Oncology" with 13 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 8 trials sponsored and "Children's Oncology Group" with 8 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pulmonary Medicine Center of Chattanooga-Hixson" #1 collaborator was "National Cancer Institute (NCI)" with 52 trials as a collaborator, "NRG Oncology" with 13 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Agenus Inc." with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Pulmonary Medicine Center of Chattanooga-Hixson" are "Recurrent Squamous Cell Lung Carcinoma" (7 trials), "Recurrent Ovarian Carcinoma" (6 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (6 trials), "Recurrent Breast Carcinoma" (5 trials) and "Recurrent Fallopian Tube Carcinoma" (4 trials). Many other conditions were trialed in "Pulmonary Medicine Center of Chattanooga-Hixson" in a lesser frequency.

Most popular intervention types in "Pulmonary Medicine Center of Chattanooga-Hixson" are "Drug" (78 trials), "Other" (69 trials), "Biological" (44 trials), "Procedure" (24 trials) and "Radiation" (7 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (44 trials), "Quality-of-Life Assessment" (21 trials), "Nivolumab" (15 trials), "Cisplatin" (13 trials) and "Carboplatin" (12 trials). Other intervention names were less common.

The vast majority of trials in "Pulmonary Medicine Center of Chattanooga-Hixson" are 78 trials for "All" genders, 21 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Pulmonary Medicine Center of Chattanooga-Hixson". undefined are not yet recruiting, 15 are recruiting, 61 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Pulmonary Medicine Center of Chattanooga-Hixson, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Pulmonary Medicine Center of Chattanooga-Hixson, 3 "Phase 1" clinical trials were conducted, 51 "Phase 2" clinical trials and 48 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".